Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5

Recent reviews suggest that chronic kidney disease (CKD) can affect the pharmacokinetics of nonrenally eliminated drugs, but the impact of CKD on individual elimination pathways has not been systematically evaluated. In this study we developed a comprehensive dataset of the effect of CKD on the phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, K, Sun, B, Zhang, L, Zhao, P, Abernethy, DR, Nolin, TD, Rostami‐Hodjegan, A, Zineh, I, Huang, S‐M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024330/
https://www.ncbi.nlm.nih.gov/pubmed/26800425
http://dx.doi.org/10.1002/cpt.337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024330/
https://www.ncbi.nlm.nih.gov/pubmed/26800425
http://dx.doi.org/10.1002/cpt.337

Ejemplares similares